Michael Pruskowski

219 Flips | 1 Magazine | 1 Following | 55 Followers | @mpruskowski | Keep up with Michael Pruskowski on Flipboard, a place to see the stories, photos, and updates that matter to you. Flipboard creates a personalized magazine full of everything, from world news to life’s great moments. Download Flipboard for free and search for “Michael Pruskowski”

Express Scripts assembling anti-Sovaldi coalition to shut out Gilead hep C drug

<i>Express Scripts CMO Steven Miller</i><p>Express Scripts ($ESRX) and Gilead Sciences ($GILD) are playing a high-priced game of chicken. At stake is the fate …

Gilead says payers feel comfortable with the cost of Sovaldi

As soon as Gilead Sciences ($GILD) named a price for its highly anticipated hep C drug Sovaldi, activists pounced--and payers showed some nervousness …

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” …

Forbes: Revolutionary Hepatitis C Drug Too Expensive? polyDNA Recommends Affordable Gene-Eden-VIR, an HCV Remedy

polyDNA recommends that doctors prescribe a safe, natural HCV remedy to their patients, which most patients can afford.<p>polyDNA has learned that …

UPDATED: Merck's 'breakthrough' hep C combo plays catch-up with promising PhII results

Merck may be playing catch-up in the race to develop the first all-oral combo treatment for hepatitis C, but it made a good case over the weekend …

Gilead Sciences, Inc. (NASDAQ:GILD) - Gilead Announces Positive Phase 3 HCV Treatment Results in Patients Co-Infected With HIV

Gilead Sciences (NASDAQ: GILD) today announced results from a Phase<br>3 study, PHOTON-1, evaluating the investigational once-daily nucleotide<br>analogue …

Eating Right - Guidelines For Hepatitis Patients

<b>Eating Right - Guidelines For Hepatitis Patients</b><p>Hope your weekend is going well folks. Here in Michigan the family spent the day collecting apples, …

Top 10 Medical Innovations for 2014: Hepatitis C Drug Sofosbuvir Number 4

Cleveland Clinic News Wire <b><br>No. 4 Innovation: A Breakthrough for Hepatitis C (Video)</b> <b><br>Better treatment in less time</b><p><i>Cleveland Clinic asked more than 100</i> …

organize, read and share what matters to you.

<b>Oops! Feedly failed to load :-(</b><p>Please try to reload https://feedly.com/ in case this is due to a networking or caching issue.<p>In some cases, some …

Know More Hepatitis

People born from 1945-1965 are 5x more likely to have Hepatitis C.<p><b>While anyone can get Hepatitis C, people born during these years are five times</b> …

NYC launches initiative to control hepatitis C prevalence in the city

The New York City Department of Health and Mental Hygiene on Monday announced the launch of an initiative to combat Hepatitis C infection, a disease …

Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients

SAN FRANCISCO – Patients with chronic hepatitis C treated with an interferon-free regimen consisting of sofosbuvir and ribavirin experienced changes …

J&J snaps up an NS5A inhibitor from GlaxoSmithKline for hep C cocktail

J&J is going to be late to the blockbuster, interferon-free hepatitis C party, but it appears determined to wrangle an invitation.<p>Rounding the bend …

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

<b></b><b>Journal of Viral Hepatitis</b><p>Volume 20, Issue 11, pages 745–760, November 2013<p><b>The new paradigm of hepatitis C therapy: integration of oral therapies</b> …

Close to 146,500 New Yorkers infected with hepatitis C; roughly 50 percent do not know it

<b>Health Department Announces Plan to Combat Hepatitis C</b><p>Approximately 146,500 New Yorkers are infected with hepatitis C; roughly 50 percent do not know …

Hepatitis C Interferon-free Combo - J&J Acquires Rights to NS5A inhibitor from GlaxoSmithKline

<b>J&J buys GSK Hep C compound, BI completes trial enrollment</b><p>Deborah Weinstein<br>October 08, 2013<p>GlaxoSmithKline sold its investigational hepatitis C NS5a …

Experience Project is taking a break. We thank our tens of millions of members for being a part of the largest community of shared experiences ever …

Philips Wants To Bring Google Glass To The Operating Room

A handful of digital health start-ups, and avant-garde surgeons are looking for ways to apply Goggle Glass to health care, but in a move that could significantly raise the profile of this nascent technology, Royal Philips is stepping in. After testing Google Glass in its labs, the Dutch giant plans …

All-Oral Therapy With Sofosbuvir and GS-0938 for 14 Days in Treatment-Naive Geno 1 Hepatitis C (NUCLEAR)

Journal of Viral Hepatitis<p><b>All-Oral Therapy With Nucleotide Inhibitors Sofosbuvir and GS-0938 for 14 Days in Treatment-Naive Genotype 1 Hepatitis C</b> …

Emerging concepts in immunity to hepatitis C virus infection.

2013 Oct;123(10):4121-30. doi: 10.1172/JCI67714. Epub 2013 Oct 1.<p>Abstract<p>Since the discovery of hepatitis C virus (HCV) by molecular cloning almost a …

Bristol-Myers Squibb to Present Range of New Hepatitis C Data at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Top 15 Drug Launch Superstars

A year ago, <i>FiercePharma</i> published a list of drugs that missed when stepping on the up escalator. A heel got caught, or a sleeve. Bystanders hit the …

AASLD an IDSA to develop updated recommendations for the management of hepatitis C

<b>Leading Liver and ID Experts to Develop Hepatitis C Practice Recommendations</b><p>Recognizing the rapid development of hepatitis C medications coupled with …